This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Cyberonics: Growth in Medical Equipment

Stocks in this article: MDTBAXCOVCYBX

CHARLOTTE, N.C. ( TheStreet) -- I like growth stocks and so should you. The object of managing your own portfolio is to whittle down the 12,000 stocks you might invest in and find the dozen you need for your portfolio that fits all of your criteria and has the best chance to beat the market.

I think the medical appliance and equipment company Cyberonics (CYBX) is that kind of stock and I'll walk you through the reasons why.

First I like to see price momentum. If the market isn't responding to a stock, why should you? In the past month the stock has been up almost 8% as you can see in this hourly trading chart provided by Barchart:







The recent momentum is there but how has the stock done against the rest of the market? During the past six months, the market as measured by the Value Line Index is up about 3% but CYBX is up 23%:







Cyberonics, a neuromodulation company, engages in the design, development, sale, and marketing of implantable medical devices that provide vagus nerve stimulation therapy for the treatment of refractory epilepsy and treatment-resistant depression. Its proprietary VNS therapy system consists of a generator to provide the stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; associated equipment to assist with implantation surgery; equipment to assist with setting the stimulation parameters particular to the patient; instruction manuals; and magnets to suspend or induce stimulation manually.

The company sells its products through a direct sales force in the U.S., as well as through a combination of direct sales representatives and independent distributors internationally. Cyberonics was founded in 1987 and is headquartered in Houston (according to a Yahoo Finance profile).

Factors to consider:

Barchart technical indicators:

  • 100% Barchart technical buy signal
  • Trend Spotter buy signal
  • Above its 20-, 50- and 100-day moving averages
  • 7 new highs and up 7.78% in the last 20 trading sessions
  • Relative Strength Index 68.78
  • Barchart computes a technical support level at 36.44
  • Recently traded at 41.62 with a 50 day moving average of 38.31




  • Fundamental factors:
  • Wall Street has already noticed this stock and six brokerage firms have assigned nine analysts to make a recommendation
  • Analysts project revenue will increase by 11.40% this year and another 13% next year
  • Earnings are estimated to increase by 16.7% this year, an additional 20.1% next year and continue at an annual rate of 26.25% over the next five years
  • These estimates resulted in five strong buy, two buy, two hold and no underperform or sell recommendations to clients
  • If the numbers hold investors should see an 11%-to-15% annual rate of return for at least five years
  • The company has a B+ financial strength rating
  • The P/E of 29.56 is higher than the market P/E of 14.40 and the stock pays no dividend
  • Medical ETFs are beginning to accumulate shares
  • The company is expanding sales in Europe and Japan
  • The research and development budget is being spent in new product development in rechargeable batteries, seizure detection and sleep apnea devices




  • Investor Interest:
  • Some of the firms with recent upgrades were Kaufman Brothers and Zachs.
  • Stock strategist Charles Payne spoke positively about the company.
  • The readers of TheStreet give the stock an A- rating.




  • Competition:

    The market is the best scorecard and I always like to invest in sector leaders by charting how the stock does against the rest of the competition. During the past year Medtronics (MDT) was down 4%, as was Covidien (COV). Baxter International (BAX) was down even further, by 13%, while Cyberonics soared 53%:

    1 of 2

    Select the service that is right for you!

    COMPARE ALL SERVICES
    Action Alerts PLUS
    Try it NOW

    Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

    Product Features:
    • $2.5+ million portfolio
    • Large-cap and dividend focus
    • Intraday trade alerts from Cramer
    • Weekly roundups
    TheStreet Quant Ratings
    Try it NOW
    Only $49.95/yr

    Access the tool that DOMINATES the Russell 2000 and the S&P 500.

    Product Features:
    • Buy, hold, or sell recommendations for over 4,300 stocks
    • Unlimited research reports on your favorite stocks
    • A custom stock screener
    • Upgrade/downgrade alerts
    Stocks Under $10
    Try it NOW

    David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

    Product Features:
    • Model portfolio
    • Stocks trading below $10
    • Intraday trade alerts
    • Weekly roundups
    Dividend Stock Advisor
    Try it NOW

    Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

    Product Features:
    • Diversified model portfolio of dividend stocks
    • Alerts when market news affect the portfolio
    • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
    Real Money Pro
    Try it NOW

    All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

    Product Features:
    • Real Money + Doug Kass Plus 15 more Wall Street Pros
    • Intraday commentary & news
    • Ultra-actionable trading ideas
    Options Profits
    Try it NOW

    Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

    Product Features:
    • 100+ monthly options trading ideas
    • Actionable options commentary & news
    • Real-time trading community
    • Options TV
    To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
    Submit an article to us!
    DOW 17,810.06 +91.06 0.51%
    S&P 500 2,063.50 +10.75 0.52%
    NASDAQ 4,712.97 +11.1030 0.24%

    Brokerage Partners

    Rates from Bankrate.com

    • Mortgage
    • Credit Cards
    • Auto

    Free Newsletters from TheStreet

    My Subscriptions:

    After the Bell

    Before the Bell

    Booyah! Newsletter

    Midday Bell

    TheStreet Top 10 Stories

    Winners & Losers

    Register for Newsletters
    Top Rated Stocks Top Rated Funds Top Rated ETFs